leadf
logo-loader
AIM:BVXP

Bioventix

Receive alerts
Market:
AIM
Market Cap:
£207.07 m
Price
3,975.00 GBX
Change
3.25%
52 weeks high
4549.24
52 weeks low
3750.00

In brief

Bioventix is a biotechnology company specialising in the development of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing.The high-affinity antibodies created at Bioventix have advantages over conventional rodent monoclonal antibodies where the target is present at low concentration, or where the target is a hapten or small molecule. The use of high-affinity SMAs also confers improved assay sensitivity and precision. Bioventix is traded in the ISDX Exchange HERE